Inventor · disambiguated record
Bryan Wayne King
Also filed as: KING BRYAN W · KING BRYAN WAYNE
16 granted patents·8 pending applications·124 citations·filing 2001–2025
92Inventor score
Files withGLAXOSMITHKLINE IP DEV LTD16BRISTOL MYERS SQUIBB CO2BRISTOL MYERS SQUIBB PHARMA CO2BODMER VERA Q1BURY MICHAEL JONATHAN1
Top patents by PatentIndex Score
24 records- 0196US9556152B2Heterocyclic amides as kinase inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2014·Granted Jan 31, 2017·29 cites·20 claims
- 0291US6495565B2β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-αBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Dec 17, 2002·50 cites·70 claims
- 0388US6927216B2Cyclic sulfonyl compounds as inhibitors of metalloproteasesBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Aug 9, 2005·22 cites·24 claims
- 0487US10933070B2Heterocyclic amides as kinase inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2019·Granted Mar 2, 2021·2 cites·4 claims
- 0586US10899716B2Heterocyclic amides as kinase inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2020·Granted Jan 26, 2021·2 cites·2 claims
- 0685US10590085B2Heterocyclic amides as kinase inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Mar 17, 2020·3 cites·31 claims
- 0784US10292987B2Heterocyclic amides as kinase inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Granted May 21, 2019·4 cites·10 claims
- 0883US10940154B2Heterocyclic amides as kinase inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2019·Granted Mar 9, 2021·3 cites·4 claims
- 0978US11771711B2Substituted pyridines as DNMT1 inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2022·Granted Oct 3, 2023·0 cites·17 claims
- 1076US11377440B2Modulators of stimulator of interferon genes (STING)GLAXOSMITHKLINE IP DEV LTD·Filed 2018·Granted Jul 5, 2022·2 cites·19 claims
- 1175US2023120185A1Heterocyclic amides as kinase inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2022·Application pending·0 cites
- 1274US2025092053A1Triazole-substituted imidazo[1,2-a]pyrimidines as cgas inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2024·Application pending·0 cites
- 1374US2025222013A1Substituted pyridines as dnmt1 inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2025·Application pending·0 cites
- 1473US12285436B2Substituted pyridines as DNMT1 inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2023·Granted Apr 29, 2025·0 cites·6 claims
- 1573US12247033B2Triazole-substituted imidazo[1,2-a]pyrimidines as cGAS inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2024·Granted Mar 11, 2025·0 cites·28 claims
- 1673US7074810B2Triazolone and triazolethione derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzymeBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Jul 11, 2006·6 cites·23 claims
- 1769US11485710B2Heterocyclic amides as kinase inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2021·Granted Nov 1, 2022·0 cites·30 claims
- 1868US10975056B2Substituted pyridines as inhibitors of DNMT1GLAXOSMITHKLINE IP DEV LTD·Filed 2017·Granted Apr 13, 2021·1 cites·21 claims
- 1944US7122560B2Lactam derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzymeBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Oct 17, 2006·0 cites·16 claims
- 2044US2016122342A1Enhancer of zeste homolog 2 inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2014·Application pending·0 cites
- 2142US2013053375A1Amino-quinolines as kinase inhibitorsBURY MICHAEL JONATHAN·Filed 2011·Application pending·0 cites
- 2241US2004072802A1Beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-alphaFiled 2002·Application pending·0 cites
- 2341US2016060222A1Amino-quinolines as kinase inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2015·Application pending·0 cites
- 2434US2013018039A1Imidazolyl-imidazoles as kinase inhibitorsBODMER VERA Q·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Bryan Wayne King files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →